ST
The company develops safer and more effective migraine medication using targeted delivery systems that enhance drug absorption and minimize side effects. This approach addresses the limitations of traditional migraine treatments, providing patients with faster relief and improved quality of life.
Updated 20 months ago
Funding
$780K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NI
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops safer and more effective migraine medication using targeted delivery systems that enhance drug absorption and minimize side effects. This approach addresses the limitations of traditional migraine treatments, providing patients with faster relief and improved quality of life.